Latest Videos

Distractions and the Doctor-Patient Relationship

Distractions and the Doctor-Patient Relationship

Posted by | Jul 2022

Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, Professor of Urology at Tulane Medical School, presents on the impact distractions have on the doctor-patient relationship. Dr. Baum reviews data on the role distracted driving plays in fatal car crashes before drawing a parallel to distractions in the exam room. He concludes that physicians should avoid and eliminate distractions in their practice by using technology to avoid data entry during an exam and setting criteria for permissible interruptions.

Read More
Utilization of Focal Therapy for Patients Discontinuing Active Surveillance of Prostate Cancer: Recommendations of an International Delphi Consensus

Utilization of Focal Therapy for Patients Discontinuing Active Surveillance of Prostate Cancer: Recommendations of an International Delphi Consensus

Posted by | Jul 2022

In this 21-minute presentation, Thomas J. Polascik, MD, FACS, Professor of Surgery at Duke University and Director of Surgical Technology at the Duke Prostate and Urological Cancer Center, posits that patients discontinuing active surveillance (AS) for prostate cancer may be good candidates for focal therapy (FT) rather than radical therapy, describing an international Delphi Consensus on the issue. Eighty-seven percent of respondents agreed that there is a role for FT for men coming off AS, citing the fact that FT is less invasive, has a greater likelihood of preserving both urinary continence and erectile function, comes with fewer side effects, and has an earlier recovery post-treatment as part of the rationale for recommending FT over radical therapy for men discontinuing AS with an imageable, biopsy-confirmed, localized cancer.

Read More
Robotic Prostatectomy: How Far Have We Come All These Years?

Robotic Prostatectomy: How Far Have We Come All These Years?

Posted by | Jul 2022

In this 11-minute video, David M. Albala, MD, Chief of Urology at Crouse Hospital in Syracuse, New York, discusses the increasing use of robotic prostatectomy and its effectiveness today. He compares robotic prostatectomy surgery to open surgery regarding perioperative outcomes, positive surgical margins, oncological outcomes, and functional outcomes.

Read More
Kidney Tumor Ablation in 2022: Optimal Outcomes

Kidney Tumor Ablation in 2022: Optimal Outcomes

Posted by | Jul 2022

Jeffrey A.Cadeddu, MD, discusses optimal outcomes in kidney tumor ablation. He reviews reliable and reproducible 5+ year data comparing ablation effectiveness and outcomes to that of surgery and emphasizes that for tumors of <3 cm, tumor ablation is indicated. Dr. Cadeddu explains that ablation is nephron-preserving and minimizes chronic kidney disease progression, is less expensive than conventional surgery, reduces risk of metastatic potential associated with AS, and in addition to tumor size, histologic subtype is an important consideration in treatment decision-making.

Read More

Join the GRU Community

- Why Join? -